GH Research PLC
GHRS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $35 | $30 | $20 | $9 |
| G&A Expenses | $15 | $11 | $10 | $7 |
| SG&A Expenses | $15 | $11 | $10 | $7 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $50 | $41 | $31 | $15 |
| Operating Income | -$50 | -$41 | -$31 | -$15 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $11 | $6 | $8 | $6 |
| Pre-Tax Income | -$39 | -$36 | -$22 | -$9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$39 | -$36 | -$22 | -$9 |
| % Margin | – | – | – | – |
| EPS | -0.75 | -0.68 | -0.14 | -0.18 |
| % Growth | -10.3% | -385.7% | 22.2% | – |
| EPS Diluted | -0.75 | -0.68 | -0.14 | -0.18 |
| Weighted Avg Shares Out | 52 | 52 | 52 | 52 |
| Weighted Avg Shares Out Dil | 52 | 52 | 52 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $2 | – | $0 |
| Interest Expense | $1 | $1 | – | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$39 | -$35 | -$22 | -$9 |
| % Margin | – | – | – | – |